In gastric cancer, a mutation of BCAT1E61A was identified in gastric cancer patients; this mutation leads to significantly elevated catalytic activity from BCAAs to BCKAs, while the ability to catalyze BCKAs to BCAAs remains similar, suggesting increased BCAA metabolism [48]. This evidence concerns the gene ARID4B and gastric cancer.